Compare VCEL & MBINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | MBINN |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | 663 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | N/A |
| IPO Year | 1997 | N/A |
| Metric | VCEL | MBINN |
|---|---|---|
| Price | $36.74 | $18.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $57.50 | N/A |
| AVG Volume (30 Days) | ★ 682.8K | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 236.54 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $258,716,999.00 | N/A |
| Revenue This Year | $17.86 | N/A |
| Revenue Next Year | $18.55 | N/A |
| P/E Ratio | $151.53 | ★ N/A |
| Revenue Growth | ★ 14.05 | N/A |
| 52 Week Low | $29.24 | N/A |
| 52 Week High | $63.00 | N/A |
| Indicator | VCEL | MBINN |
|---|---|---|
| Relative Strength Index (RSI) | 48.65 | 36.47 |
| Support Level | $35.53 | $18.50 |
| Resistance Level | $38.09 | $19.20 |
| Average True Range (ATR) | 1.33 | 0.34 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 56.52 | 40.34 |
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.